PubRank

Philip R Dormitzer

Author PubWeight™ 44.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Near-atomic resolution using electron cryomicroscopy and single-particle reconstruction. Proc Natl Acad Sci U S A 2008 5.33
2 Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc Natl Acad Sci U S A 2011 3.51
3 Molecular interactions in rotavirus assembly and uncoating seen by high-resolution cryo-EM. Proc Natl Acad Sci U S A 2009 2.65
4 Nonviral delivery of self-amplifying RNA vaccines. Proc Natl Acad Sci U S A 2012 2.59
5 SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J Biol Chem 2005 2.36
6 Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers. Proc Natl Acad Sci U S A 2011 2.08
7 Atomic model of an infectious rotavirus particle. EMBO J 2010 1.79
8 Nemaline myopathy with minicores caused by mutation of the CFL2 gene encoding the skeletal muscle actin-binding protein, cofilin-2. Am J Hum Genet 2006 1.73
9 Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody. Proc Natl Acad Sci U S A 2012 1.70
10 Structure of rotavirus outer-layer protein VP7 bound with a neutralizing Fab. Science 2009 1.66
11 Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain. J Virol 2006 1.34
12 Influenza: options to improve pandemic preparation. Science 2012 1.26
13 A cell culture-derived MF59-adjuvanted pandemic A/H7N9 vaccine is immunogenic in adults. Sci Transl Med 2014 1.22
14 Assembly of highly infectious rotavirus particles recoated with recombinant outer capsid proteins. J Virol 2006 1.20
15 High-resolution molecular and antigen structure of the VP8* core of a sialic acid-independent human rotavirus strain. J Virol 2006 1.16
16 A rotavirus spike protein conformational intermediate binds lipid bilayers. J Virol 2009 1.10
17 Alternative intermolecular contacts underlie the rotavirus VP5* two- to three-fold rearrangement. EMBO J 2006 1.06
18 VP5* rearranges when rotavirus uncoats. J Virol 2009 1.04
19 Effect of mutations in VP5 hydrophobic loops on rotavirus cell entry. J Virol 2010 0.94
20 Mutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggs. Virol J 2010 0.93
21 The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease. Vaccine 2012 0.87
22 The path to an RSV vaccine. Curr Opin Virol 2013 0.86
23 Learning from the 2009 H1N1 pandemic: prospects for more broadly effective influenza vaccines. J Mol Cell Biol 2011 0.85
24 Human RNA polymerase I-driven reverse genetics for influenza a virus in canine cells. J Virol 2010 0.84
25 Generation of a parvovirus B19 vaccine candidate. Vaccine 2013 0.82
26 Cross-linking of rotavirus outer capsid protein VP7 by antibodies or disulfides inhibits viral entry. J Virol 2011 0.81
27 Improving influenza virus backbones by including terminal regions of MDCK-adapted strains on hemagglutinin and neuraminidase gene segments. Vaccine 2013 0.80
28 H1N1: can a pandemic cycle be broken? Sci Transl Med 2010 0.80
29 Antibody affinity maturation and respiratory syncytial virus disease. Nat Med 2009 0.77
30 The epidemiology of respiratory syncytial virus lower respiratory tract infection on young children. Pediatr Infect Dis J 2012 0.75
31 Building an insurance against modern pandemics. Curr Opin Investig Drugs 2010 0.75
32 RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study. medRxiv 2020 0.75